insights_auto
Outlook: 75.0% bullish·0.0% bearish
Go to analysischevron_right
AMRX:NASDAQ
Amneal Pharmaceuticals Inc
$21.40
arrow_upward
+0.09%(+0.020) 1D
Nov 16, 10:32:45 AM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
Analyst ratings
Based on 6 analysts giving stock ratings to AMRX in the past 3 months
Strong buy
Buy
6
Hold
0
Sell
0
12-month forecast
Based on 6 Wall Street analysts offering 12 month price targets for AMRX in the last 3 months.
Highest
Current $21.40
$28.00 (+30.84%)
Average
$24.83 (+16.03%)
Lowest
$20.00 (-6.54%)
Analyst | Recommendation | Action | Price target | Projected | Date |
|---|---|---|---|---|---|
Ashwani Verma UBS | Buy | Reiterated | $28.00 | +30.8% | 11/09/2026 |
Daniel Clark Leerink Partners | Buy | Maintained | $25.00 | +16.8% | 11/05/2026 |
Chris Schott J.P. Morgan | Buy | Maintained | $25.00 | +16.8% | 11/04/2026 |
Les Sulewski Oppenheimer | Buy | Maintained | $27.00 | +26.2% | 11/03/2026 |
Unknown Analyst Oppenheimer | Buy | Maintained | $27.00 | +26.2% | 11/03/2026 |
Matthew Dellatorre Goldman Sachs | Buy | Maintained | $24.00 | +12.1% | 10/29/2026 |
Salveen Richter Goldman Sachs | Buy | Maintained | $24.00 | +12.1% | 10/29/2026 |
Glen Santangelo Barclays | Buy | Reiterated | $20.00 | -6.5% | 09/21/2026 |
David Amsellem Piper Sandler | Buy | Reiterated | $17.00 | -20.6% | 07/20/2026 |